Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. more
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | -2.92% | 0.5% |
| 1-Month Return | 5.62% | 3.86% |
| 3-Month Return | 23.76% | 1.92% |
| 6-Month Return | 31.86% | 12.03% |
| 1-Year Return | 90.76% | 18.56% |
| 3-Year Return | 126.84% | 73.83% |
| 5-Year Return | 44.71% | 70.11% |
| 10-Year Return | 175.86% | 252.93% |
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | -78.67% | 29.70% |
| 1-Month Return | 94.50% | 58.53% |
| 3-Month Return | 137.39% | 8.02% |
| 6-Month Return | 75.21% | 25.90% |
| 1-Year Return | 90.76% | 18.56% |
| 3-Year Return | 31.39% | 20.24% |
| 5-Year Return | 7.67% | 11.21% |
| 10-Year Return | 10.68% | 13.44% |
| Stock name | Ticker | Weight |
|---|---|---|
Crinetics Pharmaceuticals Inc.
|
CRNX |
4.57%
|
Apogee Therapeutics Inc.
|
APGE |
4.27%
|
CG oncology Inc.
|
CGON |
3.35%
|
Travere Therapeutics Inc.
|
TVTX |
3.12%
|
Xenon Pharmaceuticals Inc.
|
XENE |
2.96%
|
Dianthus Therapeutics Inc.
|
DNTH |
2.96%
|
Oruka Therapeutics Inc.
|
ORKA |
2.81%
|
ACADIA Pharmaceuticals Inc.
|
ACAD |
2.55%
|
Edgewise Therapeutics Inc.
|
EWTX |
2.35%
|
Definium Therapeutics Inc.
|
DFTX |
2.28%
|
Dyne Therapeutics Inc.
|
DYN |
2.12%
|
Relay Therapeutics Inc.
|
RLAY |
2.09%
|
VeraDermics Inc.
|
MANE |
2.09%
|
Amylyx Pharmaceuticals Inc.
|
AMLX |
1.98%
|
Denali Therapeutics Inc.
|
DNLI |
1.95%
|
Ideaya Biosciences Inc.
|
IDYA |
1.8%
|
Structure Therapeutics Inc.
|
GPCR |
1.72%
|
Immunome Inc.
|
IMNM |
1.6%
|
Tarsus Pharmaceuticals Inc.
|
TARS |
1.57%
|
Celldex Therapeutics Inc.
|
CLDX |
1.57%
|
Disc Medicine Inc.
|
IRON |
1.56%
|
Newamsterdam Pharma Co. NV
|
NAMS |
1.55%
|
MBX Biosciences Inc.
|
MBX |
1.53%
|
Zai Lab Ltd.
|
ZLAB |
1.45%
|
Viridian Therapeutics Inc.
|
VRDN |
1.3%
|
BioCryst Pharmaceuticals Inc.
|
BCRX |
1.28%
|
SELLAS Life Sciences Group Inc.
|
SLS |
1.26%
|
Vera Therapeutics Inc.
|
VERA |
1.25%
|
Nektar Therapeutics
|
NKTR |
1.25%
|
Rapport Therapeutics Inc.
|
RAPP |
1.19%
|
Nuvation Bio Inc.
|
NUVB |
1.19%
|
Mineralys Therapeutics Inc.
|
MLYS |
1.15%
|
Sarepta Therapeutics Inc.
|
SRPT |
1.12%
|
Palvella Therapeutics Inc.
|
PVLA |
1.09%
|
Kailera Therapeutics Inc.
|
KLRA |
1.07%
|
Vericel Corp.
|
VCEL |
1.07%
|
Agios Pharmaceuticals Inc.
|
AGIO |
1.01%
|
Stoke Therapeutics Inc.
|
STOK |
1.01%
|
Zenas Biopharma Inc.
|
ZBIO |
1.01%
|
Generate Biomedicines Inc.
|
GENB |
1%
|
Xencor Inc.
|
XNCR |
0.98%
|
Lakefront Biotherapeutics NV
|
LKFT |
0.96%
|
Immunocore Holdings PLC
|
IMCR |
0.95%
|
Compass Pathways PLC
|
CMPS |
0.95%
|
Taysha Gene Therapies Inc.
|
TSHA |
0.85%
|
Bicara Therapeutics Inc.
|
BCAX |
0.78%
|
Maze Therapeutics Inc.
|
MAZE |
0.78%
|
Tyra Biosciences Inc.
|
TYRA |
0.76%
|
ArriVent Biopharma Inc.
|
AVBP |
0.72%
|
LB Pharmaceuticals Inc.
|
LBRX |
0.7%
|
Seaport Therapeutics Inc.
|
SPTX |
0.66%
|
MeiraGTx Holdings PLC
|
MGTX |
0.65%
|
Immatics NV
|
IMTX |
0.65%
|
Alto Neuroscience Inc.
|
ANRO |
0.63%
|
MannKind Corp.
|
MNKD |
0.62%
|
Vor BioPharma Inc.
|
VOR |
0.62%
|
Corvus Pharmaceuticals Inc.
|
CRVS |
0.61%
|
Kura Oncology Inc.
|
KURA |
0.58%
|
Geron Corp.
|
GERN |
0.5%
|
Wave Life Sciences Inc.
|
WVE |
0.49%
|
Solid Biosciences Inc.
|
SLDB |
0.49%
|
Candel Therapeutics Inc.
|
CADL |
0.49%
|
Design Therapeutics Inc.
|
DSGN |
0.48%
|
Olema Pharmaceuticals Inc.
|
OLMA |
0.46%
|
Theravance Biopharma Inc.
|
TBPH |
0.45%
|
Rigel Pharmaceuticals Inc.
|
RIGL |
0.44%
|
SpyGlass Pharma Inc.
|
SGP |
0.44%
|
Aclaris Therapeutics Inc.
|
ACRS |
0.43%
|
Climb Bio Inc.
|
CLYM |
0.43%
|
4D Molecular Therapeutics Inc.
|
FDMT |
0.39%
|
Oculis Holding AG
|
OCS |
0.36%
|
Allogene Therapeutics Inc.
|
ALLO |
0.36%
|
Tectonic Therapeutic Inc.
|
TECX |
0.34%
|
AgomAb Therapeutics NV
|
AGMB |
0.33%
|
Altimmune Inc.
|
ALT |
0.31%
|
Eikon Therapeutics Inc.
|
EIKN |
0.3%
|
Neurogene Inc.
|
NGNE |
0.3%
|
Delcath Systems Inc.
|
DCTH |
0.29%
|
Contineum Therapeutics Inc.
|
CTNM |
0.29%
|
Fulgent Genetics Inc.
|
FLGT |
0.29%
|
Zura Bio Ltd.
|
ZURA |
0.28%
|
Evommune Inc.
|
EVMN |
0.24%
|
Relmada Therapeutics Inc.
|
RLMD |
0.23%
|
Rezolute Inc.
|
RZLT |
0.23%
|
Compass Therapeutics Inc.
|
CMPX |
0.22%
|
Arcturus Therapeutics Holdings Inc.
|
ARCT |
0.22%
|
C4 Therapeutics Inc.
|
CCCC |
0.22%
|
Enanta Pharmaceuticals Inc.
|
ENTA |
0.2%
|
X4 Pharmaceuticals Inc.
|
XFOR |
0.2%
|
Upstream Bio Inc.
|
UPB |
0.19%
|
Immuneering Corp.
|
IMRX |
0.17%
|
Inhibikase Therapeutics Inc.
|
IKT |
0.16%
|
SAB Biotherapeutics Inc.
|
SABS |
0.15%
|
Anavex Life Sciences Corp.
|
AVXL |
0.14%
|
Sionna Therapeutics Inc.
|
SION |
0.14%
|
MacroGenics Inc.
|
MGNX |
0.13%
|
Fulcrum Therapeutics Inc.
|
FULC |
0.13%
|
Akebia Therapeutics Inc.
|
AKBA |
0.12%
|
Protara Therapeutics Inc.
|
TARA |
0.11%
|
NovaBridge Biosciences
|
NBP |
0.11%
|
Bicycle Therapeutics PLC
|
BCYC |
0.11%
|
Immunic Inc.
|
IMUX |
0.11%
|
Tenax Therapeutics Inc.
|
TENX |
0.03%
|
Novo Nordisk A/S
|
Novo.Nordisk.A.S |
0%
|
AstraZeneca PLC
|
AstraZeneca.PLC |
0%
|
Chinook Therapeutics Inc.
|
Chinook.Therapeutics.Inc. |
0%
|
Cash Equivalent
|
USD |
-0.01%
|
| Sector | Weight |
|---|---|
|
Health care
|
100.00% |
ALPS Medical Breakthroughs ETF (SBIO) share price today is $66.086.
Yes, Indians can buy shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. To buy SBIO from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. You can start investing in ALPS Medical Breakthroughs ETF (SBIO) with a minimum investment of $1.
The 52-week high price of ALPS Medical Breakthroughs ETF (SBIO) is $70.85. The 52-week low price of ALPS Medical Breakthroughs ETF (SBIO) is $34.88.
The stock symbol (or ticker) of ALPS Medical Breakthroughs ETF is SBIO.
Yes, you can setup SIP in ALPS Medical Breakthroughs ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of SBIO on the Vested app.
The expense ratio of ALPS Medical Breakthroughs ETF (SBIO) is 0.5%.
Link copied